Abstract
Bronchiolitis obliterans organizing pneumonia (BOOP) is defined by buds of granulation tissue within lung distal airspaces. The diagnosis requires the histopathologic evidence of organizing pneumonia along with a suggestive clinical and radiographic pattern. This disorder is characterized by a good response to corticosteroids and an excellent prognosis. It can occur in association with a broad spectrum of clinical conditions or can be isolated, in this last case named cryptogenic organizing pneumonia. We searched for BOOP in patients with autoimmune rheumatic diseases (ARD) in the literature, and we found 32 well-documented cases. We reported here demographic features, manifestations, treatment and outcome of patients with BOOP associated with ARD. Notably, BOOP can be the presenting feature in some patients with ARD; thus, a close follow-up of patients with BOOP is recommended.
Similar content being viewed by others
References
Cordier JF. Cryptogenic organising pneumonia. Eur Respir J. 2006;28:422–46.
Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN. Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med. 2008;3:67–75.
Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med. 2001;161:158–64.
King TE. Cryptogenic organizing pneumonia. In: www.uptodate.com. 2013. http://www.uptodate/contents/cryptogenic-organizing-pneumonia/contributors. (Accessed 14 Jan 2014).
Sveinsson OA, Isakson HJ, Gudmundsson G. Organising pneumonia—a review and results from Icelandic studies. Laeknabladid. 2008;94:27–35.
Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltim). 1995;74:201–11.
Roos JC, Chilvers ER, Ostor AJ. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy. J Rheumatol. 2007;34:238–9.
Villeneuve E, St-Pierre A, Haraoui B. Interstitial pneumonitis associated with infliximab therapy. J Rheumatol. 2006;33:1189–93.
Perez-Alvarez R, Perez-de-Lis M, Diaz-Lagares C, et al. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum. 2011;41:256–64.
Ostör AJ, Chilvers ER, Somerville MF, et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol. 2006;33:622–8.
Cho SK, Oh IH, Park CK, Bae SC, Sung YK. Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis. Rheumatol Int. 2012;32:1055–7.
Sakaida H, Komase Y, Takemura T. Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept. Mod Rheumatol. 2010;20:611–6.
Ikegawa K, Hanaoka M, Ushiki A, Yamamoto H, Kubo K. A case of organizing pneumonia induced by tocilizumab. Intern Med. 2011;50:2191–3.
Godeau B, Cormier C, Menkes CJ. Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide. Ann Rheum Dis. 1991;50:956–8.
Weber F, Prior C, Kowald E, Schmuth M, Sepp N. Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus. Br J Dermatol. 2000;143:453–5.
Purcell IF, Bourke SJ, Marshall SM. Cyclophosphamide in severe steroid-resistant bronchiolitis obliterans organizing pneumonia. Respir Med. 1997;91:175–7.
Kondoh Y, Taki F, Ando M, et al. A case of bronchiolitis obliterans organizing pneumonia in a patient with rheumatoid arthritis who responded to corticosteroid and immunosupressant therapy. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30:1165–70.
Shinohara T, Hidaka T, Matsuki Y, et al. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med. 1997;36:519–23.
Koinuma D, Miki M, Ebina M, et al. Successful treatment of a case with rapidly progressive Bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid. Intern Med. 2002;41:26–9.
Kobayashi I, Yamada M, Takahashi Y, et al. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A. Rheumatology (Oxf). 2003;42:371–4.
Yáñez VJ, Cisternas MM, Saldías HV, Saldías PF. Refractory dermatomyositis associated with chronic organizing pneumonia treated with rituximab: report of one case. Rev Med Chile. 2009;137:88–93.
Laszlo A, Espolio Y, Auckenthaler A, Michel JP, Janssens JP. Azathioprine and low-dose corticosteroids for the treatment of cryptogenic organizing pneumonia in an older patient. J Am Geriatr Soc. 2003;51:433–4.
Lee YH, Choi SJ, Ji JD, Shim JJ, et al. Dermatomyositis without elevation of creatine kinase presented as bronchiolitis obliterans organizing pneumonia. Korean J Intern Med. 2000;15:85–8.
Strobel ES, Bonnet RB, Werner P, Schaefer HE, Peter HH. Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosis-like lung involvement in a patient with primary biliary cirrhosis. Clin Rheumatol. 1998;17:246–9.
Yoo JW, Song JW, Jang SJ, Lee CK, et al. Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia. Rheumatology (Oxf). 2011;50:932–8.
Cohen AJ, King TE Jr, Downey GP. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med. 1994;149:1670–5.
Knoell KA, Hook M, Grice P, Hendrix JD. Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP). J Am Acad Dermatol. 1999;40:328–30.
Chan WM, Lau CS, Wang E, Peh WC. Anti-Jo-1 syndrome presenting as cryptogenic organizing pneumonia. Respir Med. 1995;89:639–41.
Henriet AC, Diot E, Marchand-Adam S, et al. Organising pneumonia can be the inaugural manifestation in connective tissue diseases, including Sjogren’s syndrome. Eur Respir Rev. 2010;19:161–3.
Takada H, Saito Y, Nomura A, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in systemic lupus erythematosus. Pediatr Pulmonol. 2005;40:257–60.
Gammon RB, Bridges TA, Al-Nezir H, Alexander CB, Kennedy JI. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest. 1992;102:1171–4.
Kalenian M, Zweiman B. Inflammatory myopathy, bronchiolitis obliterans organizing pneumonia and anti-Jo-1 antibodies an interesting association. Clin Diagn Lab Immunol. 1997;4:236–40.
Shimizu Y, Tsukagoshi H, Nemoto T, et al. Recurrent bronchiolitis obliterans organizing pneumonia in a patient with limited cutaneous systemic sclerosis. Rheumatol Int. 2002;22:216–8.
Taylor JG, Bolster MB. Bronchiolitis obliterans with organizing pneumonia associated with scleroderma and scleroderma spectrum diseases. J Clin Rheumatol. 2003;9:239–45.
Otsuka F, Amano T, Hashimoto N, et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody. Intern Med. 1996;35:341–4.
Krishnappriya R, Gupta R, Christopher DJ, Balamugesh T, James P. Bronchiolitis obliterans organising pneumonia in systemic lupus erythematosus with anti-phospholipid antibody syndrome—an unusual presentation. Clin Respir J. 2010;4:125–6.
Hsue YT, Paulus HE, Coulson WF. Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with long term survival. J Rheumatol. 1993;20:877–9.
Imasaki T, Yoshi A, Tanaka S, et al. Polymyositis and Sjögren’s syndrome associated with bronchiolitis obliterans organizing pneumonia. Intern Med. 1996;35:231–5.
Fata F, Rathore R, Schiff C, Herzlich BC. Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis. South Med J. 1997;90:227–30.
Xing M, Lansdale TF, McNamara CF, et al. Bronchiolitis obliterans with organizing pneumonia (BOOP) heralding anti-Jo-1-positive polymyositis. J Clin Rheumatol. 1999;5:219–23.
Devos FG, Leleu O, Aubry P, Jounieaux V. Bronchiolitis obliterans organizing pneumonia associated with dermatomyositis and antiphospholipid syndrome. Rev Mal Respir. 2002;19:249–51.
Park SH, Kum YS, Kim KC, et al. Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature. Rheumatol Int. 2009;29:1231–5.
Mane F, Mets T, Vzncken W, et al. The association of bronchiolitis obliterans organizing pneumonia, systemic lupus erythematosus, and Hunner’s cystitis. Chest. 1993;104:642–4.
Lambert M, Hebbar M, Viget N, et al. Bronchiolite oblitkante avec pneumopathie organike: une complication rare du syndrome de Gougerot–Sjiigren primitive. M Rev MCd Interne. 2000;21:74–7.
Ioannou S, Toya SP, Tomos P, Tzelepis GE. Cryptogenic organizing pneumonia associated with primary Sjogren’s syndrome. Rheumatol Int. 2008;28:1053–5.
Nakamura H, Kita J, Kawakami A, et al. Multiple bone fracture due to Fanconi’s syndrome in primary Sjögren’s syndrome complicated with organizing pneumonia. Rheumatol Int. 2009;30:265–7.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rojas, C.M.L., Borella, E., Palma, L. et al. Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases. Immunol Res 61, 97–103 (2015). https://doi.org/10.1007/s12026-014-8607-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-014-8607-z